Meeting Archive:
History of PH: Mechanisms & Physiology

This event has already taken place. The recording will be available soon on PHA Classroom.
 
PHA is always scheduling more webinars on relevant and important topics. We have more than 160 recordings posted from past live events and our international conference. For more information on upcoming webinars or to watch recordings, visit PHA Classroom.
 

Meeting Description:
Join this interactive discussion on the history of pulmonary hypertension (PH). This will be the first presentation of a two-part series, and will focus on the evolution of our understanding of the mechanisms and physiology of PH. The webinar will consist of an interview with a panel of experts considered to be among the founders of the modern PH field.
 
Interviewer:
  • Stephen Mathai, MD, Johns Hopkins University School of Medicine
Panelists:
  • Bruce Brundage, MD, St. Charles Medical Center - Bend
  • C. Gregory Elliott, MD, Intermountain Medical Center
  • Lewis Rubin, MD, University of California, San Diego, Thornton Hospital
The second webinar in this series, History of PH: Progress in Clinical Management, will take place in early 2014. Panelists will include:
  • David Badesch, MD, University of Colorado, Denver
  • Michael McGoon, MD, Mayo Clinic
  • Stuart Rich, MD, University of Chicago
Details
Date: Fri, Dec 6, 2013
Time: 01:00 PM EST
Duration: 1 hour
Host(s): PHA Classroom & PHA Online University
 Presenter Information
Bruce Brundage, MD
Speaker Photo

Bruce H. Brundage, MD, is Emeritus Professor of Medicine at David Geffen UCLA, School of Medicine and served as Chief of Cardiology at Harbor-UCLA Medical Center. He received his MD at UMDNJ–New Jersey Medical School, completed his internship at Tripler Army Medical Center, Honolulu (rotating internship), his internal medicine residency at Fitzsimons Army Medical Center, Denver, and his cardiology fellowship at Letterman Army Medical Center, San Francisco. In 1990, Dr. Brundage accepted the above positions at UCLA and as Scientific Director of the St. Johns Cardiovascular Research Center. Dr. Brundage published over 150 peer-reviewed manuscripts and edited 2 textbooks. Throughout his career he received multiple research grants, and served as PI in the study that first demonstrated the effectiveness of calcium channel-blockers in reducing pulmonary artery pressures. He was the first Chair of PHA’s Scientific Leadership Council and the first physician to Chair PHA’s Board of Trustees.

C. Gregory Elliott, MD
Speaker Photo

C. Greg Elliott, MD, is Professor of Medicine at the University of Utah School of Medicine and Chairman of the Department of Medicine at Intermountain Medical Center. He received his MD at the University of Maryland School of Medicine. His internship, residency, and Chief Medical Residency were completed at the University of Maryland Hospitals. His pulmonary and critical care fellowship was completed at the University of Utah School of Medicine. His research and patient care focus is pulmonary hypertension and pulmonary vascular diseases. Dr. Elliott aims to advance our understanding and treatment of pulmonary hypertensive disease.  He has helped to develop and test new treatments and to understand the genetics (inheritance) of this disease. Dr. Elliott has authored or co-authored more than 90 original manuscripts in peer reviewed journals, in addition to numerous book chapters, editorials, and invited reviews. He is a past Chair of PHA's Scientific Leadership Council.

Stephen Mathai, MD
Speaker Photo

Stephen C. Mathai, MD, MHS, is Assistant Professor in the Division of Pulmonary and Critical Care at Johns Hopkins University School of Medicine. Dr. Mathai received his MD at Jefferson Medical College, and went on to complete his internship, residency and chief medical residency at Thomas Jefferson University Hospital. He then completed his fellowship in pulmonary and critical care medicine at Johns Hopkins University School of Medicine and his MHS in clinical investigation at Johns Hopkins Bloomberg School of Public Health. He has authored and reviewed many scholarly publications and serves as investigator in many research studies. Dr. Mathai is a current member of PHA’s Scientific Leadership Council.

Lewis Rubin, MD
Speaker Photo

Lewis J. Rubin, MD, FACP, FCCP, FAHA, FRCP, is Emeritus Professor of Medicine at the University of California in San Diego, School of Medicine and its emeritus director of Pulmonary and Critical Care. Professor Rubin earned his medical degree from the Albert Einstein College of Medicine, New York, and completed a residency and fellowship at Duke University Medical Center. He has been involved in the basic and clinical investigation of pulmonary vascular diseases for more than 30 years. He has authored over 200 peer-reviewed publications and 70 book chapters, and edited six books on the pulmonary circulation. He has served as Principal Investigator/Steering Committee Chair or Member for the pivotal trials of most of the currently approved medical therapies for PAH. Dr. Rubin previously served as a member of PHA’s Scientific Leadership Council.